View Publication On PubMed
Export A series of novel pyrazolyl amide-chalcones conjugates was synthesized in five steps and evaluated against a range of medically important kinetoplastid parasites including Trypanosoma cruzi, Trypanosoma brucei brucei, Trypanosoma brucei rhodesiense and Leishmania infantum. In addition, the series was also tested for in vitro cytotoxicity activity against human lung fibroblasts and primary mouse macrophages. Among all synthetised compounds, 9b was found to be the most active against T. b. brucei with an IC(50) value of 0.51 +/- 0.06 muM. Against T. b. rhodesiense, 9n was found to be the most potent with an IC(50) value of 0.46 +/- 0.07 muM. While against L. infantum, 9a was found to be most active with an IC(50) value of 7.16 +/- 1.88 muM. Based on the results and SAR, further modifications will be carried out to increase potency.
SEEK ID: https://fairdomhub.org/publications/767
PubMed ID: 39432069
Projects: WG1 - Compound libraries coordination and integration of compound design, WG2 - Integration of early phase studies and low environmental impact ac..., WG3 - Coordination of in vitro-to-in vivo translation of OneHealth leads..., WG4 - Integration of R&D process-environmental studies and translation i...
Publication type: Journal Article
Journal: Naunyn Schmiedebergs Arch Pharmacol
Citation: Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr;398(4):4199-4210. doi: 10.1007/s00210-024-03524-7. Epub 2024 Oct 21.
Date Published: 9th Apr 2025
Registered Mode: by PubMed ID
SubmitterViews: 8
Created: 14th Jul 2026 at 08:00
TagsThis item has not yet been tagged.
AttributionsNone
Download
https://orcid.org/0000-0002-4870-3202